DrugPatentWatch Database Preview
Pertuzumab - Biologic Drug Details
Summary for pertuzumab
Tradenames: | 1 |
Patents: | 177 |
Applicants: | 1 |
BLAs: | 1 |
Suppliers: see list | 1 |
Recent Clinical Trials: | See clinical trials for pertuzumab |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for pertuzumab |
Recent Clinical Trials for pertuzumab
Identify potential brand extensions & biosimilar entrants
Sponsor | Phase |
---|---|
Guangdong General Hospital | Phase 2 |
Seattle Genetics, Inc. | Phase 3 |
NanoString Technologies, Inc. | Phase 2 |
Recent Litigation for pertuzumab
Identify key patents and potential future biosimilar entrants
District Court Litigation
Case Name | Date |
---|---|
CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. | 2019-07-12 |
Genentech, Inc. v. Amgen Inc. | 2018-06-21 |
Celltrion, Inc. v. Genentech, Inc. | 2018-01-11 |
Pharmacology for pertuzumab
Mechanism of Action | HER2/Neu/cerbB2 Antagonists |
Patent Text Search: US Patents for pertuzumab
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Celgene Corporation (Summit, NJ) | 2039-02-26 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2025-01-21 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2025-05-20 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Hoffmann-La Roche Inc. (Nutley, NJ) | 2025-08-12 | RX | search | |
Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Genentech, Inc. (South San Francisco, CA) | 2039-02-26 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for pertuzumab
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 6243345 | Start Trial |
New Zealand | 553029 | Start Trial |
South Africa | 201004730 | Start Trial |
Russian Federation | 2016130501 | Start Trial |
South Africa | 201001383 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for pertuzumab
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
2015 | Austria | Start Trial | PRODUCT NAME: POMALIDOMID UND SEINE PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE, HYDRATE ODER STEREOISOMERE; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
2 50002-2015 | Slovakia | Start Trial | PRODUCT NAME: POMALIDOMID; REGISTRATION NO/DATE: EU/1/13/850/001 - EU/1/13/850/004 20130808 |
642 | Luxembourg | Start Trial | PRODUCT NAME: POMALIDOMIDE ET SES SELS, SOLVATES, HYDRATES OU STEREOISOMERES PHARMACEUTIQUEMENT ACCEPTABLES QUI EN DERIVENT (IMNOVID); FIRST REGISTRATION DATE: 20130805 |
00717 | Netherlands | Start Trial | PRODUCT NAME: POMALIDOMIDE EN FARMACEUTISCH AANVAARDBARE ZOUTEN, SOLVATEN, HYDRATEN OF STEREOISOMEREN DAARVAN; REGISTRATION NO/DATE: EU/1/13/850 20130805 |
140 | Estonia | Start Trial | |
>Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |